Live Status Check

NCT06586957 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 6:29 AM UTC

NCT06586957 Status Summary

NCT NumberNCT06586957
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment150 participants
Active Locations19 sites in the US
SponsorNiKang Therapeutics, Inc.
Last Updated on CT.govApril 21, 2026 (Apr 21, 2026)

About NCT06586957 Enrollment Status

As of July 13, 2026: Clinical trial NCT06586957 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 19 locations across the United States. The study is sponsored by NiKang Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06586957

Is NCT06586957 still recruiting?

Yes, NCT06586957 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06586957 recruiting?

This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06586957?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06586957 status last updated?

The official ClinicalTrials.gov record for NCT06586957 was last updated Apr 21, 2026 (April 21, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial